Functional evolution of tissue factor, the archetype of the cytokine receptor family

Current Genomics

Volumn 6, Issue 6, 2005, Pages 367-373

  Spek, C Arnold ^a   van Zoelen, Marieke ^a   Diks, Sander H ^b   Peppelenbosch, Maikel P ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Chordates; Cytokines receptors; Prokariotic secretion system 2; Tissue factor

Indexed keywords

CYTOKINE RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; INTERFERON RECEPTOR; JANUS KINASE; STAT PROTEIN; THROMBOPLASTIN;

BLOOD CLOTTING; EUKARYOTE; GENETIC DATABASE; GENOMICS; MOLECULAR EVOLUTION; NONHUMAN; PROKARYOTE; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

CHORDATA; EUKARYOTA; HEXAPODA; INVERTEBRATA; PROKARYOTA;

EID: 27944471029     PISSN: 13892029     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920205774483025     Document Type: Review

References (27)

1. Buchanan, A. On the coagulation of the blood and other fibriniferous liquids. London Medical Gazette 1845, 2: 1844-1848.
2. Bãchli, E. History of tissue factor. Br. J Haematol. 2000, 110: 248-255.
3. Howell, W.H. Theories of blood coagulation. Physiologic Review 1935, 15: 435-470.
4. Chargraff, E.; Bendich, A. and Cohen, S.S. The thromboplastic protein: structure, properties, disintegration. J Biochem. 1994. 156: 161-178.
5. Davie, E.W. and Ratnoff, O.D. Waterfall sequence for intrinsic blood clotting. Science 1964, 145: 1310-1312.
6. MacFarlane, R.G. An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature 1964, 202: 498-499.
7. Osterud, B. and Rapaport, S.I. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc. Natl. Acad. Sci. USA 1977, 74: 5260-5264.
8. Bach, R.; Nemerson, Y. and Konigsberg, W. Purification and characterization of bovine tissue factor. J. Biol. Chem. 1981, 256: 8324-8331.
9. Bach, R.R. Initiation of coagulation by tissue factor. CRC Crit. Rev. Biochem 1988, 23: 339-368.
10. Roberts, H.R.; Monroe, D.M.; Oliver, J.A.; Chang, J.Y. and Hoffman, M. Newer concepts of blood coagulation. Haemophilia 1998, 4: 331-334.
11. Veldman, A.; Hoffman, M. and Ehrenforth, S. New insights into the coagulation system and implications for new therapeutic options with recombinant factor VIIa. Curr. Med. Chem. 2003, 10: 797-811.
12. Hoffman, M. A cell-based model of coagulation and the role of factor VIIa. Blood Rev. 2003, 17: S1-5.
13. Broze, G.J. Jr. Tissue factor pathway inhibitor and the current concept of blood coagulation. Blood Coagul. Fibrinolysis 1995, 6(suppl): S7-13.
14. Spek, C.A. Tissue factor: from 'just one of the coagulation factors' to a major player in physiology. Blood Coagul. Fibrinolysis 2004, Suppl 1: S3-10.
15. Peppelenbosch, M.P. and Versteeg, H.H. Cell biology of tissue factor, an unusual member of the cytokine receptor family. Trends Cardiovasc. Med. 2001, 11: 335-9.
16. Bazan, J.F. Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl. Acad Sci. USA 1990, 87: 6934-8.
17. Peppelenbosch, M.P.; Versteeg, H.H. and Spek, C.A. In silico tissue factor analysis: a bit-to-bit comparison. Thromb. Haemost. 2003, 89: 592-3.
18. Sorensen, B.B.; Freskgard, P.O.; Nielsen, L.S.; Rao, L.V.; Ezban, M. and Petersen, L.C. Factor VIIa-induced p44/42 mitogen-activated protein kinase activation requires the proteolytic activity of factor VIIa and is independent of the tissue factor cytoplasmic domain. J Biol. Chem. 1999, 274: 21349-54.
19. Melis, E.; Moons, L.; De Mol, M.; Herbert, J.M.; Mackman, N.; Collen, D.; Carmeliet, P. and Dewerchin, M. Targeted deletion of the cytosolic domain of tissue factor in mice does not affect development. Biochem. Biophys. Res. Commun. 2001, 286: 580-6.
20. Ott, I.; Fischer, E.G.; Miyagi, Y.; Mueller, B.M. and Ruf, W. A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280. J. Cell. Biol. 1998, 140: 1241-53.
21. Belting, M.; Dorrell, M.I.; Sandgren, S.; Aguilar, E.; Ahamed, J.; Dorfleutner, A.; Carmeliet, P.; Mueller, B.M.; Friedlander, M. and Ruf, W. Regulation of angiogenesis by tissue factor cytoplasmic domain signaling. Nat. Med. 2004, 10: 502-9.
22. Ahamed, J. and Ruf, W. Protease-activated receptor 2-dependent phosphorylation of the tissue factor cytoplasmic domain. J. Biol. Chem. 2004, 279: 23038-44.
23. Ott, I.; Michaelis, C.; Schuermann, M.; Steppich, B.; Seitz, I.; Dewerchin, M.; Zohlnhofer, D.; Wessely, R.; Rudelius, M.; Schomig, A. and Carmeliet, P. Vascular remodeling in mice lacking the cytoplasmic domain of tissue factor. Circ. Res. 2005, 97: 293-8.
24. Versteeg, H.H.; Spek, C.A.; Slofstra, S.H.; Diks, S.H.; Richel, D.J. and Peppelenbosch, M.P. FVIIa:TF induces cell survival via G12/GI3-dependent Jak/STAT activation and BcIXL production. Circ. Res. 2004, 94: 1032-40.
25. Kotenko, S.V. and Pestka, S. Jak-Stat signal transduction pathway through the eyes of cytokine class II receptor complexes. Oncogene 2000, 19: 2557-65.
26. Diks, S.H. and Peppelenbosch, M.P. Single cell proteomics for personalised medicine. Trends Mol Med. 2004, 10: 574-7.
27. Diks, S.H.; Kok, K.; O'Toole, T.; Hommes, D.W.; van Dijken, P.; Joore, J. and Peppelenbosch, M.P. Kinome profiling for studying lipopolysaccharide signal transduction in human peripheral blood mononuclear cells. J. Biol. Chem. 2004, 279: 49206-13.